Resona Asset Management’s Pfizer PFE Stock Holding History

Resona Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.6M	Sell	1,806,609 -126,645	-7%	-$3.31M	0.2%	89
2026 Q1	$54.2M	Buy	1,933,254 +13,944	+0.7%	+$371K	0.27%	72
2025 Q4	$47.8M	Sell	1,919,310 -100,455	-5%	-$2.53M	0.23%	87
2025 Q3	$51M	Sell	2,019,765 -96,601	-5%	-$2.38M	0.24%	80
2025 Q2	$51.3M	Buy	2,116,366 +112,794	+6%	+$2.63M	0.25%	78
2025 Q1	$50.7M	Buy	2,003,572 +158,262	+9%	+$4.14M	0.29%	66
2024 Q4	$49M	Sell	1,845,310 -90,942	-5%	-$2.47M	0.29%	62
2024 Q3	$56.1M	Sell	1,936,252 -43,253	-2%	-$1.26M	0.32%	58
2024 Q2	$55.3M	Sell	1,979,505 -203,214	-9%	-$5.59M	0.33%	55
2024 Q1	$60.6M	Buy	+2,182,719	New	+$60.6M	0.36%	55

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Resona Asset Management's PFE Position: Q2 2026 in Review

Resona Asset Management reduced its Pfizer (PFE) stake by 6.6% in Q2 2026, selling an estimated $3.31M and leaving 1,806,609 shares worth $43.6M. The position accounts for 0.2% of the portfolio, ranked #89.

Resona Asset Management first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $60.6M in Q1 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Resona Asset Management held 1,806,609 shares of Pfizer worth $43.6M as of Q2 2026.
Resona Asset Management sold 126,645 Pfizer shares in Q2 2026, an estimated $3.31M.
Pfizer made up 0.2% of Resona Asset Management's portfolio in Q2 2026, its #89 holding.
Resona Asset Management first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Pfizer position peaked at $60.6M in Q1 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.